HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.

Abstract
Both herpes simplex virus type 1 (HSV-1) and HSV-2 encode a thymidine kinase enzyme which differs from cellular thymidine kinase in substrate specificity. Viral thymidine kinase enables the virus to replicate in cells that lack cellular thymidine kinase, namely those of the sensory neurons where the virus establishes, and periodically reactivates from, a latent state. Thymidine kinase-dependent HSV replication following viral reactivation at the site of latency is thought to precede the emergence of virus at mucosal surfaces. The ability to inhibit such an essential viral enzyme would potentially prevent HSV from replicating within neuronal tissue, and thus stop the recurrent disease cycle. Ro 32-2313 was designed as a selective and competitive inhibitor of HSV thymidine kinase and in vitro studies have confirmed this mechanism of action. In vivo evaluation of a soluble prodrug of Ro 32-2313, Ro 32-4397, was undertaken in murine models where pathogenesis was dependent upon viral replication in neuronal tissue. It was shown that in vivo administration of Ro 32-4397 (i) significantly reduced the viral titre detected in isolated dorsal root ganglia; (ii) prevented HSV-2-induced lethality in a systemic infection model; and (iii) reduced zosteriform lesion development in a model of dermal infection. Administration of Ro 32-4397 produced dose-related changes in viral pathogenicity towards those of the phenotype of a thymidine kinase-deficient virus. Overall, the study confirmed that thymidine kinase inhibitors can suppress the replication of HSV in vivo, and suggest that such inhibitors may reduce reactivation of the virus from latency if used prophylactically in recurrent HSV infection.
AuthorsA M Watkins, P J Dunford, A M Moffatt, P Wong-Kai-In, M J Holland, D S Pole, G M Thomas, J Martin, N A Roberts, M J Mulqueen
JournalAntiviral chemistry & chemotherapy (Antivir Chem Chemother) Vol. 9 Issue 1 Pg. 9-18 (Jan 1998) ISSN: 0956-3202 [Print] England
PMID9875372 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Enzyme Inhibitors
  • Ro 32-2313
  • Ro 32-4397
  • Thymidine Kinase
  • Thymidine
Topics
  • Animals
  • Antiviral Agents (pharmacology)
  • Chlorocebus aethiops
  • Cricetinae
  • Enzyme Inhibitors (pharmacology)
  • Female
  • Ganglia (virology)
  • Herpesvirus 1, Human (drug effects, enzymology, physiology)
  • Herpesvirus 2, Human (drug effects, enzymology, physiology)
  • Mice
  • Mice, Inbred BALB C
  • Thymidine (analogs & derivatives, pharmacology)
  • Thymidine Kinase (antagonists & inhibitors)
  • Vero Cells
  • Virus Latency
  • Virus Replication (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: